Literature DB >> 11287398

Characterization of cerebrosides from the thermally dimorphic mycopathogen Histoplasma capsulatum: expression of 2-hydroxy fatty N-acyl (E)-Delta(3)-unsaturation correlates with the yeast-mycelium phase transition.

M S Toledo1, S B Levery, E Suzuki, A H Straus, H K Takahashi.   

Abstract

Cerebroside (monohexosylceramide) components were identified in neutral lipids extracted from both the yeast and mycelial forms of the thermally dimorphic mycopathogen Histoplasma capsulatum. The components were purified from both forms and their structures elucidated by 1- and 2-dimensional nuclear magnetic resonance (NMR) spectroscopy, electrospray ionization mass spectrometry (ESI-MS), and low energy tandem collision-induced dissociation mass spectrometry (ESI-MS/CID-MS). Both components were characterized as beta-glucopyranosylceramides (GlcCers) containing (4E,8E)-9-methyl-4,8-sphingadienine as the long-chain base, attached to 18-carbon 2-hydroxy fatty N-acyl components. However, while the fatty acid of the yeast form GlcCer was virtually all N-2'-hydroxyoctadecanoate, the mycelium form GlcCer was characterized by almost exclusive expression of N-2'-hydroxy-(E)-delta(3)-octadecenoate. These results suggest that the yeast-mycelium transition is accompanied by up-regulation of an as yet uncharacterized ceramide or cerebroside 2-hydroxy fatty N-acyl (E)-delta(3)-desaturase activity. They also constitute further evidence for the existence of two distinct pathways for ceramide biosynthesis in fungi, since glycosylinositol phosphorylceramides (GIPCs), the other major class of fungal glycosphingolipids, are found with ceramides consisting of 4-hydroxysphinganine (phytosphingosine) and longer chain 2-hydroxy fatty acids. In addition to identification of the major glucocerebroside components, minor components (< 5%) detectable by molecular weight differences in the ESI-MS profiles were also characterized by tandem ESI-MS/CID-MS analysis. These minor components were identified as variants differing in fatty acyl chain length, or the absence of the sphingoid 9-methyl group or (E)-delta(8)-unsaturation, and are hypothesized to be either biosynthetic intermediates or the result of imperfect chemical transformation by the enzymes responsible for these features. Possible implications of these findings with respect to chemotaxonomy, compartmentalization of fungal glycosphingolipid biosynthetic pathways, and regulation of morphological transitions in H.capsulatum and other dimorphic fungi are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287398     DOI: 10.1093/glycob/11.2.113

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  17 in total

Review 1.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 2.  Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.

Authors:  Ryan Rhome; Travis McQuiston; Talar Kechichian; Alicja Bielawska; Mirko Hennig; Monica Drago; Giulia Morace; Chiara Luberto; Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2007-08-10

3.  Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.

Authors:  Philipp C Rittershaus; Talar B Kechichian; Jeremy C Allegood; Alfred H Merrill; Mirko Hennig; Chiara Luberto; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

4.  Identification and functional characterization of the 2-hydroxy fatty N-acyl-Delta3(E)-desaturase from Fusarium graminearum.

Authors:  Simone Zaüner; Ulrich Zähringer; Buko Lindner; Dirk Warnecke; Petra Sperling
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

5.  SREB, a GATA transcription factor that directs disparate fates in Blastomyces dermatitidis including morphogenesis and siderophore biosynthesis.

Authors:  Gregory M Gauthier; Thomas D Sullivan; Sergio S Gallardo; T Tristan Brandhorst; Amber J Vanden Wymelenberg; Christina A Cuomo; Garret Suen; Cameron R Currie; Bruce S Klein
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

6.  Effect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manpalpha1-->3Manpalpha1-->2IPC.

Authors:  Marcos S Toledo; Loriane Tagliari; Erika Suzuki; Claudinei M Silva; Anita H Straus; Helio K Takahashi
Journal:  BMC Microbiol       Date:  2010-02-15       Impact factor: 3.605

7.  Neutral storage lipids of Histoplasma capsulatum: effect of culture age.

Authors:  Robert Zarnowski; Agnieszka Dobrzyn; James M Ntambi; Jon P Woods
Journal:  Curr Microbiol       Date:  2007-10-25       Impact factor: 2.188

8.  Structural analysis of fungal cerebrosides.

Authors:  Eliana Barreto-Bergter; Guilherme L Sassaki; Lauro M de Souza
Journal:  Front Microbiol       Date:  2011-12-05       Impact factor: 5.640

9.  Surface architecture of histoplasma capsulatum.

Authors:  Allan J Guimarães; Mariana D de Cerqueira; Joshua D Nosanchuk
Journal:  Front Microbiol       Date:  2011-11-18       Impact factor: 5.640

Review 10.  Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols.

Authors:  Sarah T Pruett; Anatoliy Bushnev; Kerri Hagedorn; Madhura Adiga; Christopher A Haynes; M Cameron Sullards; Dennis C Liotta; Alfred H Merrill
Journal:  J Lipid Res       Date:  2008-05-21       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.